시장보고서

상품코드

1609545

수술중 신경 모니터링 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 정보원별, 유형별, 지역별, 부문별 예측(2025-2030년)

Intraoperative Neuromonitoring Market Size, Share & Trends Analysis Report By Product, By Source, By Type, By Region, And Segment Forecasts, 2025 - 2030

발행일: 2024년 11월 | 리서치사:

Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

수술중 신경 모니터링 시장 성장과 동향:

세계 수술중 신경 모니터링 시장 규모는 2030년 46억 6,000만 달러에 달할 것으로 예상되며, 예측 기간 동안 5.97%의 CAGR로 성장할 것으로 예상됩니다.

이러한 성장은 기술 발전, 기기 안전에 대한 인식 증가, 노인 인구 증가에 기인하며, COVID-19의 발생은 시장에 이중으로 영향을 미칠 것으로 예상되며, 2020년 3월 미국 외과 학회(ACS)는 미국에서 COVID-19의 급속한 증가로 인해 선택적 수술의 축소, 연기 및 중단을 제안하는 성명을 발표하였습니다. 수술의 축소, 연기, 중단을 제안하는 성명을 발표했는데, 이는 성장에 걸림돌이 될 것으로 예상됩니다.

또한, Elsevier 저널에 게재된 연구(국제 출혈성 뇌졸중 협회, 2021년 1월)에 따르면, 입원 중인 COVID-19 환자의 최대 36%가 신경학적 증상을 보일 수 있으며, 허혈성 및 출혈성 경색과 관련된 사례가 여러 건 발견되었습니다. 또한 2021년 6월 Neurology Online Journal에 게재된 또 다른 최근 연구에 따르면 COVID-19 바이러스가 새로운 신경 질환의 발병에 관여할 수 있음을 시사했습니다. 새로운 질환의 증가로 인해 병원 내 사망 위험이 증가하고 퇴원율이 감소하고 있습니다. 이러한 특징은 예측 기간 동안 유리한 성장을 가져올 것으로 예상됩니다.

또한, 신경외과수술 건수 증가, 수술의 경제성 증가, 환자 안전에 대한 중요성 증가로 인해 이 시장은 성장할 것으로 예상됩니다. 수술중 신경 모니터링(IONM)은 재수술 횟수를 줄이고 수술 후 합병증과 후유증 발생을 줄일 수 있기 때문에 병원은 다양한 수술에 적용하고 있습니다.

수술중 신경 모니터링 시장 보고서 하이라이트

유형별로는 2024년 병원 부문이 52.72%로 가장 큰 점유율을 차지했습니다. 이는 환자뿐만 아니라 의사들 사이에서도 IONM의 장점에 대한 인식이 높아지면서 병원이 복잡한 수술 시 IONM을 사용하게 되었기 때문으로 추정됩니다. 이것이 IONM이 이 시장에서 우위를 점하고 있는 주요 이유입니다.
지역별로는 북미가 2024년 49.35%로 가장 큰 점유율을 차지했습니다. 유리한 상환 시나리오와 기술 발전이 이러한 우위의 요인입니다.
유럽의 수술중 신경 모니터링 시장은 예측 기간 동안 6.38%의 CAGR로 급성장할 것으로 예상됩니다.

수술중 신경 모니터링 시장 : 유형 전망과 중요한 포인트
수술중 신경 모니터링 시장 : 유형 변동 분석
유형별
단속적인 모니터링
- 단속적 모니터링 시장 매출 추정과 예측, 2018-2030년
지속적인 모니터링
- 지속적 모니터링 시장 매출 추정과 예측, 2018-2030년

제7장 수술중 신경 모니터링 시장 : 지역 추정·동향 분석

지역 대시보드
시장 규모와 예측 동향 분석, 2018년에서 2030년 :
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 노르웨이
- 스웨덴
- 덴마크
아시아태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
라틴아메리카
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트
- 쿠웨이트

제8장 경쟁 구도

시장 진출 기업 분류
주요 시장 진출 기업의 최근 동향과 영향 분석
기업 시장 점유율 분석, 2024년
주요 기업 개요
- Natus Medical Incorporated
- Medtronic
- Accurate Monitoring
- Neuromonitoring Technologies
- NuVasive, Inc.
- SpecialtyCare, LLC
- Neurosoft
- Ambu A/S
- Brainlab(Dr. Langer Medical GmbH)
- Welcony(Neurosign UK Ltd.)

ksm 24.12.27

Intraoperative Neuromonitoring Market Growth & Trends:

The global intraoperative neuromonitoring market size is expected to reach USD 4.66 billion in 2030 and is anticipated to grow at a CAGR of 5.97% over the forecast period. This growth can be attributed to technological advancements, increasing awareness regarding the safety of the devices, and the growing geriatric population. The COVID-19 outbreak is expected to have a dual impact on the market. In March 2020, the American College of Surgeons (ACS) published a proposal to reduce, postpone, or cancel elective surgeries as COVID-19 cases grew quickly in the U.S., which is expected to hamper growth.

Moreover, according to a research study published in Elsevier journal (International Hemorrhagic Stroke Association; Jan 2021), up to 36% of hospitalized COVID-19 patients might exhibit neurological symptoms, and there were several cases related to ischemic & hemorrhagic infarction. In addition, another recent research study published in Neurology Online Journal in June 2021 proposed that the COVID-19 virus might be responsible for patients acquiring novel neurological diseases. Owing to the growth of new diseases, there is a higher risk of in-hospital mortality and a low discharge rate. These characteristics are expected to result in lucrative growth over the forecast period.

Furthermore, the market is expected to witness growth due to the increasing number & affordability of neurosurgeries and the growing emphasis on patient safety in surgeries. Hospitals are adopting Intraoperative Neuromonitoring (IONM) in a wide spectrum of surgeries, as it reduces the number of revision surgeries and results in fewer postoperative complications & cases of permanent impairment.

Intraoperative Neuromonitoring Market Report Highlights:

By type, the insourced segment accounted for the largest share of 52.72% in 2024. This can be attributed to growing awareness among physicians as well as patients about the benefits of IONM, which results in the hospitals utilizing IONM during complex procedures. This is a key reason for the dominance of insourced IONM in the market
By region, North America accounted for the largest share of 49.35% in 2024. Favorable reimbursement scenarios along with technological advancements can be attributed to this dominance
The intraoperative neuromonitoring market in Europe is anticipated to grow fastest with a CAGR of 6.38% during the forecast period

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Source
- 1.2.3. Type
- 1.2.4. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Approach 1: Commodity flow approach
- 1.7.3. Volume price analysis (Model 2)
- 1.7.4. Approach 2: Volume price analysis
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Regional outlook
2.4. Competitive Insights

Chapter 3. Intraoperative Neuromonitoring Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent Market Outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
  - 3.2.1.1. Increasing demand for IONM in hospitals
  - 3.2.1.2. Technological advancements in intraoperative neuromonitoring systems
  - 3.2.1.3. Increasing prevalence of neurovascular disorders
- 3.2.2. Market Restraint Analysis
  - 3.2.2.1. Complex regulatory framework
  - 3.2.2.2. Surgery-associated risk
3.3. Intraoperative Neuromonitoring Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Bargaining power of suppliers
  - 3.3.1.2. Bargaining power of buyers
  - 3.3.1.3. Threat of substitutes
  - 3.3.1.4. Threat of new entrants
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Economic landscape
  - 3.3.2.3. Social landscape
  - 3.3.2.4. Technological landscape
  - 3.3.2.5. Environmental landscape
  - 3.3.2.6. Legal landscape

Chapter 4. Intraoperative Neuromonitoring Market - Segment Analysis, by Product, 2018 - 2030 (USD Million)

4.1. Intraoperative Neuromonitoring Market: Product Outlook and Key Takeaways
4.2. Intraoperative Neuromonitoring Market: Product Movement Analysis
4.3. Intraoperative Neuromonitoring Market Estimates & Forecast, by Product (USD Million)
4.4. Systems
- 4.4.1. Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.5. Disposables
- 4.5.2. EMG Tubes And Electrodes
  - 4.5.2.1. EMG Tubes And Electrodes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.3. Sticker Electrode
  - 4.5.3.1. Sticker Electrode Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
- 4.5.4. Stimulating Probes
  - 4.5.4.1. Stimulating Probes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Intraoperative Neuromonitoring Market - Segment Analysis, by Source, 2018 - 2030 (USD Million)

5.1. Intraoperative Neuromonitoring Market: Source Outlook and Key Takeaways
5.2. Intraoperative Neuromonitoring Market: Source Movement Analysis
5.3. Intraoperative Neuromonitoring Market Estimates & Forecast, by Source (USD Million)
5.4. Insourced
- 5.4.1. Insourced Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Outsourced
- 5.5.1. Outsourced Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Intraoperative Neuromonitoring Market - Segment Analysis, by Type, 2018 - 2030 (USD Million)

6.1. Intraoperative Neuromonitoring Market: Type Outlook and Key Takeaways
6.2. Intraoperative Neuromonitoring Market: Type Movement Analysis
6.3. Intraoperative Neuromonitoring Market Estimates & Forecast, by Type (USD Million)
6.4. Intermittent Monitoring
- 6.4.1. Intermittent Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Continuous Monitoring
- 6.5.1. Continuous Monitoring Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Intraoperative Neuromonitoring Market: Regional Estimates & Trend Analysis

7.1. Regional Dashboard
7.2. Market Size & Forecasts Trend Analysis, 2018 to 2030:
7.3. North America
- 7.3.1. U.S.
  - 7.3.1.1. Key country dynamics
  - 7.3.1.2. Regulatory framework/ reimbursement structure
  - 7.3.1.3. Competitive scenario
  - 7.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.2. Canada
  - 7.3.2.1. Key country dynamics
  - 7.3.2.2. Regulatory framework/ reimbursement structure
  - 7.3.2.3. Competitive scenario
  - 7.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.3.3. Mexico
  - 7.3.3.1. Key country dynamics
  - 7.3.3.2. Regulatory framework/ reimbursement structure
  - 7.3.3.3. Competitive scenario
  - 7.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
7.4. Europe
- 7.4.1. UK
  - 7.4.1.1. Key country dynamics
  - 7.4.1.2. Regulatory framework/ reimbursement structure
  - 7.4.1.3. Competitive scenario
  - 7.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.2. Germany
  - 7.4.2.1. Key country dynamics
  - 7.4.2.2. Regulatory framework/ reimbursement structure
  - 7.4.2.3. Competitive scenario
  - 7.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. France
  - 7.4.3.1. Key country dynamics
  - 7.4.3.2. Regulatory framework/ reimbursement structure
  - 7.4.3.3. Competitive scenario
  - 7.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.4. Italy
  - 7.4.4.1. Key country dynamics
  - 7.4.4.2. Regulatory framework/ reimbursement structure
  - 7.4.4.3. Competitive scenario
  - 7.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.5. Spain
  - 7.4.5.1. Key country dynamics
  - 7.4.5.2. Regulatory framework/ reimbursement structure
  - 7.4.5.3. Competitive scenario
  - 7.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.6. Norway
  - 7.4.6.1. Key country dynamics
  - 7.4.6.2. Regulatory framework/ reimbursement structure
  - 7.4.6.3. Competitive scenario
  - 7.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.7. Sweden
  - 7.4.7.1. Key country dynamics
  - 7.4.7.2. Regulatory framework/ reimbursement structure
  - 7.4.7.3. Competitive scenario
  - 7.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.8. Denmark
  - 7.4.8.1. Key country dynamics
  - 7.4.8.2. Regulatory framework/ reimbursement structure
  - 7.4.8.3. Competitive scenario
  - 7.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
7.5. Asia Pacific
- 7.5.1. Japan
  - 7.5.1.1. Key country dynamics
  - 7.5.1.2. Regulatory framework/ reimbursement structure
  - 7.5.1.3. Competitive scenario
  - 7.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. China
  - 7.5.2.1. Key country dynamics
  - 7.5.2.2. Regulatory framework/ reimbursement structure
  - 7.5.2.3. Competitive scenario
  - 7.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. India
  - 7.5.3.1. Key country dynamics
  - 7.5.3.2. Regulatory framework/ reimbursement structure
  - 7.5.3.3. Competitive scenario
  - 7.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.4. Australia
  - 7.5.4.1. Key country dynamics
  - 7.5.4.2. Regulatory framework/ reimbursement structure
  - 7.5.4.3. Competitive scenario
  - 7.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.5. South Korea
  - 7.5.5.1. Key country dynamics
  - 7.5.5.2. Regulatory framework/ reimbursement structure
  - 7.5.5.3. Competitive scenario
  - 7.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.6. Thailand
  - 7.5.6.1. Key country dynamics
  - 7.5.6.2. Regulatory framework/ reimbursement structure
  - 7.5.6.3. Competitive scenario
  - 7.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
7.6. Latin America
- 7.6.1. Brazil
  - 7.6.1.1. Key country dynamics
  - 7.6.1.2. Regulatory framework/ reimbursement structure
  - 7.6.1.3. Competitive scenario
  - 7.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Argentina
  - 7.6.2.1. Key country dynamics
  - 7.6.2.2. Regulatory framework/ reimbursement structure
  - 7.6.2.3. Competitive scenario
  - 7.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
7.7. MEA
- 7.7.1. South Africa
  - 7.7.1.1. Key country dynamics
  - 7.7.1.2. Regulatory framework/ reimbursement structure
  - 7.7.1.3. Competitive scenario
  - 7.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. Saudi Arabia
  - 7.7.2.1. Key country dynamics
  - 7.7.2.2. Regulatory framework/ reimbursement structure
  - 7.7.2.3. Competitive scenario
  - 7.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. UAE
  - 7.7.3.1. Key country dynamics
  - 7.7.3.2. Regulatory framework/ reimbursement structure
  - 7.7.3.3. Competitive scenario
  - 7.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.4. Kuwait
  - 7.7.4.1. Key country dynamics
  - 7.7.4.2. Regulatory framework/ reimbursement structure
  - 7.7.4.3. Competitive scenario
  - 7.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Market Participant Categorization
8.2. Recent Developments & Impact Analysis by Key Market Participants
8.3. Company Market Share Analysis, 2024
8.4. Key Company Profiles
- 8.4.1. Natus Medical Incorporated
  - 8.4.1.1. Company overview
  - 8.4.1.2. Financial performance
  - 8.4.1.3. Product benchmarking
  - 8.4.1.4. Strategic initiatives
- 8.4.2. Medtronic
  - 8.4.2.1. Company overview
  - 8.4.2.2. Financial performance
  - 8.4.2.3. Product benchmarking
  - 8.4.2.4. Strategic initiatives
- 8.4.3. Accurate Monitoring
  - 8.4.3.1. Company overview
  - 8.4.3.2. Financial performance
  - 8.4.3.3. Product benchmarking
  - 8.4.3.4. Strategic initiatives
- 8.4.4. Neuromonitoring Technologies
  - 8.4.4.1. Company overview
  - 8.4.4.2. Financial performance
  - 8.4.4.3. Product benchmarking
  - 8.4.4.4. Strategic initiatives
- 8.4.5. NuVasive, Inc.
  - 8.4.5.1. Company overview
  - 8.4.5.2. Financial performance
  - 8.4.5.3. Product benchmarking
  - 8.4.5.4. Strategic initiatives
- 8.4.6. SpecialtyCare, LLC
  - 8.4.6.1. Company overview
  - 8.4.6.2. Financial performance
  - 8.4.6.3. Product benchmarking
  - 8.4.6.4. Strategic initiatives
- 8.4.7. Neurosoft
  - 8.4.7.1. Company overview
  - 8.4.7.2. Financial performance
  - 8.4.7.3. Product benchmarking
  - 8.4.7.4. Strategic initiatives
- 8.4.8. Ambu A/S
  - 8.4.8.1. Company overview
  - 8.4.8.2. Financial performance
  - 8.4.8.3. Product benchmarking
  - 8.4.8.4. Strategic initiatives
- 8.4.9. Brainlab (Dr. Langer Medical GmbH)
  - 8.4.9.1. Company overview
  - 8.4.9.2. Financial performance
  - 8.4.9.3. Product benchmarking
  - 8.4.9.4. Strategic initiatives
- 8.4.10. Welcony (Neurosign UK Ltd.)
  - 8.4.10.1. Company overview
  - 8.4.10.2. Financial performance
  - 8.4.10.3. Product benchmarking
  - 8.4.10.4. Strategic initiatives

수술중 신경 모니터링 시장 규모, 점유율, 동향 분석 보고서 : 제품별, 정보원별, 유형별, 지역별, 부문별 예측(2025-2030년)

Intraoperative Neuromonitoring Market Size, Share & Trends Analysis Report By Product, By Source, By Type, By Region, And Segment Forecasts, 2025 - 2030

수술중 신경 모니터링 시장 성장과 동향:

수술중 신경 모니터링 시장 보고서 하이라이트

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 수술중 신경 모니터링 변수, 동향, 범위

제4장 수술중 신경 모니터링 시장 - 부문 분석, 제품별, 2018-2030년

제5장 수술중 신경 모니터링 시장 - 부문 분석, 정보원별, 2018-2030년

제6장 수술중 신경 모니터링 시장 - 부문 분석, 유형별, 2018-2030년